EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.24.3 | Adenocarcinoma |
2157947 |
[New direct assay method of type IV collagenase in tissue homogenate and biochemical role of collagenase against type I, and IV collagens to the invasion of the stomach and lung cancer] |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
4
0 |
| 3.4.24.3 | Adenoma |
7629646 |
[Study of type I and IV collagenase activity in human thyroid diseases] |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
4
0 |
| 3.4.24.3 | Anthrax |
22214451 |
Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs. |
therapeutic application
unassigned |
4
0 |
| 3.4.24.3 | Anti-Glomerular Basement Membrane Disease |
7679459 |
Heterogeneity of antibodies in Goodpasture syndrome reacting with type IV collagen. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 3.4.24.3 | Arthritis |
7512303 |
Innervation of the patella. An immunohistochemical study in mice. |
unassigned |
0 |
| 3.4.24.3 | Arthritis |
16542506 |
Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. |
diagnostic usage
ongoing research
unassigned |
1
1
0 |
| 3.4.24.3 | Arthritis, Rheumatoid |
213904 |
[Detection of collagenase in passive haemagglutination using collagen-coated erythrocytes (author's transl)] |
ongoing research
unassigned |
3
0 |
| 3.4.24.3 | Bell Palsy |
26825794 |
DTB Select: 2 | February 2016. |
diagnostic usage
therapeutic application
unassigned |
3
1
0 |
| 3.4.24.3 | Bone Resorption |
7606891 |
H-31 human breast cancer cells stimulate type I collagenase production in osteoblast-like cells and induce bone resorption. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
4
1
0 |
| 3.4.24.3 | Brain Edema |
9109878 |
Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
3
4
0 |
